Tortoise Investment Management’s BioNTech BNTX Stock Holding History

Tortoise Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500	Closed	-$49.3K	–	388
2025 Q3	$49.3K	Hold	500	–	–	﹤0.01%	395
2025 Q2	$53.2K	Hold	500	–	–	0.01%	373
2025 Q1	$45.5K	Hold	500	–	–	﹤0.01%	388
2024 Q4	$57K	Hold	500	–	–	0.01%	401
2024 Q3	$59.4K	Hold	500	–	–	0.01%	384
2024 Q2	$40.2K	Hold	500	–	–	﹤0.01%	421
2024 Q1	$46.1K	Hold	500	–	–	0.01%	386
2023 Q4	$52.8K	Hold	500	–	–	0.01%	348
2023 Q3	$54.3K	Hold	500	–	–	0.01%	337
2023 Q2	$54K	Hold	500	–	–	0.01%	345
2023 Q1	$62.3K	Hold	500	–	–	0.01%	312
2022 Q4	$75.1K	Hold	500	–	–	0.01%	290
2022 Q3	$67K	Hold	500	–	–	0.01%	280
2022 Q2	$75K	Hold	500	–	–	0.01%	252
2022 Q1	$85K	Buy	+500	New	+$84K	0.02%	243

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tortoise Investment Management's BNTX Position: Q4 2025 in Review

Tortoise Investment Management sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 500 shares — an estimated $49.3K sold.

Tortoise Investment Management first reported a position in BNTX in Q1 2022 and held it in 15 quarters. The position peaked at $85K in Q1 2022. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

Tortoise Investment Management reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
Tortoise Investment Management sold 500 BioNTech shares in Q4 2025, an estimated $49.3K.
Tortoise Investment Management first reported a position in BioNTech in Q1 2022 and held it in 15 quarters.
Tortoise Investment Management's BioNTech position peaked at $85K in Q1 2022.
284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.